首页> 外文会议>World biomaterials congress >Interactions of zoledronate and alendronate with hydroxyapatite and octacalciumphosphate
【24h】

Interactions of zoledronate and alendronate with hydroxyapatite and octacalciumphosphate

机译:唑来膦酸盐和阿仑膦酸盐与羟基磷灰石和磷酸八钙的相互作用

获取原文

摘要

Introduction: Bisphosphonates (BPs) are recognized as potent inhibitors of osteoclast activity and widely used clinically for the treatment of diseases associated with conditions of bone loss. It is known that BPs act directly on osteoclasts and interfere with specific intracellular biochemical processes such as isoprenoid biosynthesis and subsequent protein prenylation to inhibit cell activity . The ability to bind to bone mineral is the key of their pharmacological action as well as of the efficacy and action duration. The mineral affinity and activity of individual BPs depend on the two covalently bound sidechains, R1 and R2, attached to the central carbon atom (Scheme 1). It has been reported that zoledronate (Zol) displays a greater binding affinity than alendronate (Al) towards apatite (HA) surface . Due to its important role as precursor of biological HA, octacalciumphosphate (OCP) is a good candidate for the preparation of composites for bone tissue repair. In this work we modified the classical procedure of OCP synthesis in order to prepare OCP-AI and OCP-Zol crystals at different concentration of the BPs and we demonstrate the higher affinity of Al for OCP. Materials and Methods: The synthesis of OCP, in the presence of Al and Zol, was carried out by dropwise addition of a Ca(CH3COO)2 solution into a phosphate solution. The reaction was carried out at 70°C under mechanical stirring. The precipitate was stored in contact with the mother solution for 30 min before dropwise addition of the bisphosphonate solution. Finally the precipitate was filtered, repeatedly washed with distilled water and dried. Zol and Al concentrations were in the range from 0.1 to 1.2 mM. The powders were characterized by X-Ray and SEM analysis, whereas BPs content was determined spectrophotometrically via complex formation with Fe(lll) ions. Results and Discussion: By using both BPs we obtained OCP as the unique crystalline phase, as confirmed by the results of XRD analysis. Al and Zol content in the solid products increased on increasing their concentration in solution up to about 5.5% and 3.5%, respectively. Al and Zol presence during the OCP synthesis caused a reduction of the mean length of the coherently scattering domains and a reduction in the dimensions of the composite crystals compared to those of pure OCP. The data suggest different mechanisms of interaction of Zol and Al with OCP structure, which can be justified by the results of the study of calcium coordination environment. Figure 1: possible interaction of Al with the hydrated layer of OCP structure Conclusions: The different behavior of Zol and Al towards incorporation into OCP, with respect to that previously observed for HA PIM suggests different mechanisms of interaction between the BPs and the calcium phosphates in the composites, which provide materials with tunable antiresorptJve properties and promising potential orthopedic applications.
机译:简介:双膦酸盐(BPs)被认为是破骨细胞活性的有效抑制剂,在临床上广泛用于治疗与骨质流失相关的疾病。众所周知,BP直接作用于破骨细胞并干扰特定的细胞内生化过程,例如类异戊二烯的生物合成和随后的蛋白质异戊二烯化,从而抑制细胞活性。结合骨矿物质的能力是其药理作用以及功效和作用持续时间的关键。单个BP的矿物亲和力和活性取决于两个共价结合的侧链R1和R2,它们连接到中心碳原子上(方案1)。据报道,唑来膦酸盐(Zol)对磷灰石(HA)表面显示出比阿仑膦酸盐(Al)更大的结合亲和力。由于其作为生物HA的重要前体,磷酸八钙(OCP)是制备用于骨组织修复的复合材料的良好候选者。在这项工作中,我们修改了OCP合成的经典程序,以便在不同的BP浓度下制备OCP-AI和OCP-Zol晶体,并证明了Al对OCP的亲和力更高。材料和方法:在Al和Zol存在下,通过将Ca(CH3COO)2溶液滴加到磷酸盐溶液中进行OCP的合成。反应在70℃下在机械搅拌下进行。在逐滴添加双膦酸酯溶液之前,将沉淀物与母液接触保存30分钟。最后,将沉淀物过滤,用蒸馏水反复洗涤并干燥。 Zol和Al的浓度范围是0.1到1.2 mM。通过X射线和SEM分析表征粉末,而BPs含量通过与Fe(III)离子形成络合物分光光度法测定。结果与讨论:XRD分析结果证实,通过使用这两种BP,我们获得了OCP作为独特的结晶相。固体产物中Al和Zol的含量随溶液中浓度的增加分别增加至约5.5%和3.5%。与纯OCP相比,OCP合成过程中Al和Zol的存在导致相干散射域的平均长度减小,复合晶体的尺寸减小。数据表明Zol和Al与OCP结构的相互作用机理不同,这可以通过钙配位环境的研究结果来证明。图1:Al与OCP结构的水合层可能发生的相互作用结论:与先前观察到的HA PIM相比,Zol和Al在掺入OCP中的不同行为表明BP与磷酸钙之间存在不同的相互作用机理。这种复合材料可为材料提供可调节的抗骨吸收特性,并有望在骨科领域应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号